Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant - Priority Announcement: Infection and Immunity (Bridge Funding)

Université de Montréal

$100,000.00

Ubiquitination of HSV-1 virions and capsids

FY 2008-09

Summary
Herpes simplex virus type 1 (HSV-1) is the causative agent of cold sores and a major cause of blindness. When it infects us, it is recognized and elicits a number of responses. A typical and well characterized outcome is an immune response against the virus. However, other responses are also put in place. One of them is to modify viral proteins in a way that leads to their degradation, hence potentially neutralizing the virus. This process is called ubiquitination. However, ubiquitination also controls numerous other cellular events. We have recently found that the virus incorporates several ubiquitinated proteins and ubiquitin enzymes, but the reason and outcome of such incorporation remain elusive at the moment. We consequently propose to examine this more closely in an effort to understand the role of these modifications, how it serves the virus and how the virus evades degradation. In the long run, it is hoped this may lead to novel methods to control these all too common pathogens.
Program
Operating Grant - Priority Announcement: Infection and Immunity (Bridge Funding)
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
183463
Name
Lippé Roger
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Virology & Viral Pathogenesis
Projecttitle
Ubiquitination of HSV-1 virions and capsids
Programtype2
Operating Grants
Orgnameinp2
Université de Montréal
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: Infection and Immunity (Bridge Funding)
Keyworddelim
Herpes; Hsv-1; In Vitro Assay; Intracellular Transport; Proteomic; Ubiquitin
Abstract
Herpes simplex virus type 1 (HSV-1) is the causative agent of cold sores and a major cause of blindness. When it infects us, it is recognized and elicits a number of responses. A typical and well characterized outcome is an immune response against the virus. However, other responses are also put in place. One of them is to modify viral proteins in a way that leads to their degradation, hence potentially neutralizing the virus. This process is called ubiquitination. However, ubiquitination also controls numerous other cellular events. We have recently found that the virus incorporates several ubiquitinated proteins and ubiquitin enzymes, but the reason and outcome of such incorporation remain elusive at the moment. We consequently propose to examine this more closely in an effort to understand the role of these modifications, how it serves the virus and how the virus evades degradation. In the long run, it is hoped this may lead to novel methods to control these all too common pathogens.
Competitiondate
200809
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lippé, Roger
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~